Stephanie Pfaender
Overview
Explore the profile of Stephanie Pfaender including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
100
Citations
2213
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Paniskaki K, Goretzki S, Anft M, Konik M, Meister T, Pfaender S, et al.
Pediatr Allergy Immunol
. 2023 Dec;
34(12):e14060.
PMID: 38146118
Background: A proportion of the convalescent SARS-CoV-2 pediatric population presents nonspecific symptoms, mental health problems, and a reduction in quality of life similar to myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) and...
12.
Heinen N, Khanal R, Westhoven S, Klohn M, Herrmann S, Herrmann M, et al.
Gut
. 2023 Dec;
73(10):e14.
PMID: 38123990
No abstract available.
13.
Paniskaki K, Goretzki S, Anft M, Konik M, Lechtenberg K, Vogl M, et al.
BMC Infect Dis
. 2023 Nov;
23(1):818.
PMID: 37993788
Cross-reactive cellular and humoral immunity can substantially contribute to antiviral defense against SARS-CoV-2 variants of concern (VOC). While the adult SARS-CoV-2 cellular and humoral immunity and its cross-recognition potential against...
14.
Paniskaki K, Konik M, Anft M, Heidecke H, Meister T, Pfaender S, et al.
Front Microbiol
. 2023 Jun;
14:1196721.
PMID: 37333646
The role of adaptive SARS-CoV-2 specific immunity in post-acute sequelae of COVID-19 (PASC) is not well explored, although a growing population of convalescent COVID-19 patients with manifestation of PASC is...
15.
Overheu O, Lendowski S, Quast D, Kuhn D, Vidal Blanco E, Kraeft A, et al.
J Cancer Res Clin Oncol
. 2023 Jun;
149(12):10633-10644.
PMID: 37300723
Purpose: The SARS-CoV-2 Omicron variant of concern (VOC) and subvariants like BQ.1.1 demonstrate immune evasive potential. Little is known about the efficacy of booster vaccinations regarding this VOC and subvariants...
16.
Simsek A, Bessen C, Meister T, Urlaub D, Skaletz-Rorowski A, Brockmeyer N, et al.
J Eur Acad Dermatol Venereol
. 2023 Mar;
37(7):e825-e827.
PMID: 36912717
No abstract available.
17.
Anft M, Skrzypczyk S, Frahnert M, Fricke L, Zapka J, Kuhn D, et al.
Kidney Int Rep
. 2023 Jan;
8(4):939-941.
PMID: 36712412
No abstract available.
18.
Anft M, Skrzypczyk S, Frahnert M, Fricke L, Zapka J, Kuhn D, et al.
Kidney Int Rep
. 2023 Jan;
8(3):685-687.
PMID: 36644711
No abstract available.
19.
Bessen C, Plaza-Sirvent C, Simsek A, Bhat J, Marheinecke C, Urlaub D, et al.
Front Immunol
. 2022 Dec;
13:1049070.
PMID: 36532034
Despite the development of vaccines, which protect healthy people from severe and life-threatening Covid-19, the immunological responses of people with secondary immunodeficiencies to these vaccines remain incompletely understood. Here, we...
20.
Faissner S, Heitmann N, Rohling R, Ceylan U, Bongert M, Plaza-Sirvent C, et al.
Ther Adv Neurol Disord
. 2022 Dec;
15:17562864221141505.
PMID: 36518553
Background: The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic has tremendous implications for the management of patients with autoimmune conditions such as multiple sclerosis (MS) under immune therapies targeting...